| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |